6 March 2024 · Timely use of rasburicase for treatment of Tumour Lysis Syndrome is essential. Mitigation strategies can minimise harm associated with delayed therapy.
28 February 2024 · Discussion of key current medication safety challenges within healthcare with a focus on the safe use of valproate; inspiring partnership across the system
19 December 2022 · A number of resources are available to support the safe use of high-risk medicines. Healthcare professionals should ensure they are available for their patients
21 September 2022 · Safety risks and mitigation strategies are described to reduce the risk of errors with intravenous paracetamol in neonates, infants, and children.
7 September 2022 · Healthcare professionals who use vitamin D should be aware of the risks of toxicity and safe practice principles which may prevent patient harm
7 September 2022 · Healthcare professionals involved in the use of metolazone need to be aware of the differences between licensed and unlicensed products to ensure safe care.
15 November 2021 · Potassium permanganate is a chemical product. We review the evidence for using it in wound care and highlight the risk of severe harm associated with wrong use.
9 July 2021 · Serious side effects can be caused if betamethasone soluble tablets used as mouthwash are swallowed. Providing clear patient directions can help prevent harm